2021-06-14
Published Date
Healthcare
Industry
105
Pages
The global Hemophilia Treatment market is growing with significant growth from last couple of years. In the year 2020, the market of Hemophilia Treatment was valued at USD XX Million and is expected to reach USD XXX million by the end of the year 2027. ,
The report is designed to offer very important and crucial information about the Hemophilia Treatment market and industry. For the purpose of this study, the market of Hemophilia Treatment has been segmented into type, application, regions and countries. Each segment of the report will provide a detailed analysis of the market in terms of quantitative and qualitative information, the report offers market revenue (USD Million), market share in %, market CAGR from 2021 to 2027.
The report provides a detailed qualitative analysis of the Hemophilia Treatment market which includes Market Drivers to explain the driving factors of the market and demand, Market Challenges to explain the restraints of the market and growth and Market Opportunities to explain the upcoming trends and opportunities left for the newcomers of the market and where can the existing companies focus in order to gain competitive advantage. The Hemophilia Treatment report also provides a detailed Porter's Five Forces, Micro and Macro Economic analysis which can help the readers and the users of the report to understand and draw a sound business decision.
The readers of the report will have a deep , insightful analysis that will help in understanding the market size, market share, CAGR, country specific analysis and market share for Hemophilia Treatment market.
Market Segmentation
One of the very important chapter of Hemophilia Treatment market report is competitive analysis. In this chapter, we have presented a detailed overview of the competition and have provided the market revenue of each company along with the market share.
The companies mentioned in the report are:
CSL Behring
Baxalta
Pfizer Inc
BioMarin
Bayer Healthcare
Biogen
Novo Nordisk
Roche
Shire Plc
Note: We can also add companies which are not part of the above list
Global Hemophilia Treatment Market Analysis By Type
On-demand
prophylaxis
In the year 2020, On-demand segment had XX% of market share and in terms of value, the On-demand market was valued at USD XX Million. , It is expected that On-demand will have XX% of market share by the end of year 2027 and the incremental growth from 2021 till 2027 is expected to be USD XX Million.
Global Hemophilia Treatment Market Analysis By Application
Replacement therapy
ITI therapy
Gene therapy
Replacement therapy segment is expected to account for XX% of market share by the end of year 2027 from XX% in 2020. The Replacement therapy segment is expected to grow at USD XX million by the end of year 2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The following regions has been further bifurcated into countries to provide an insightful analysis for the readers.
Global Hemophilia Treatment market: regional analysis, the major regions covered in the report are:
North America
Europe
China
Japan
Southeast Asia
India
The study objectives are:
To analyze and research the Hemophilia Treatment Market status and future forecast.
To present the key Hemophilia Treatment Market analysis of companies and present revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Frequently Asked Questions - FAQ:
How big is the opportunity for the Hemophilia Treatment market
What are the recent industry development that can be implemented to generate additional revenue streams
Who are the major players operating in the Hemophilia Treatment market Which companies are the front runners
Table of Contents
Executive Summary
1 Industry Overview of Hemophilia Treatment
1.1 Definition of Hemophilia Treatment
1.2 Hemophilia Treatment Segment by Type
1.2.1 Global Hemophilia Treatment Production Growth Rate Comparison by Types (2016-2027)
1.2.2 On-demand
1.2.3 prophylaxis
1.3 Hemophilia Treatment Segment by Applications
1.3.1 Global Hemophilia Treatment Consumption Comparison by Applications (2016-2027)
1.3.2 Replacement therapy
1.3.3 ITI therapy
1.3.4 Gene therapy
1.4 Global Hemophilia Treatment Overall Market
1.4.1 Global Hemophilia Treatment Revenue (2016-2027)
1.4.2 Global Hemophilia Treatment Production (2016-2027)
1.4.3 North America Hemophilia Treatment Status and Prospect (2016-2027)
1.4.4 Europe Hemophilia Treatment Status and Prospect (2016-2027)
1.4.5 China Hemophilia Treatment Status and Prospect (2016-2027)
1.4.6 Japan Hemophilia Treatment Status and Prospect (2016-2027)
1.4.7 Southeast Asia Hemophilia Treatment Status and Prospect (2016-2027)
1.4.8 India Hemophilia Treatment Status and Prospect (2016-2027)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Hemophilia Treatment
2.3 Manufacturing Process Analysis of Hemophilia Treatment
2.4 Industry Chain Structure of Hemophilia Treatment
3 Development and Manufacturing Plants Analysis of Hemophilia Treatment
3.1 Capacity and Commercial Production Date
3.2 Global Hemophilia Treatment Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Hemophilia Treatment
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Hemophilia Treatment Production and Capacity Analysis
4.2 Hemophilia Treatment Revenue Analysis
4.3 Hemophilia Treatment Price Analysis
4.4 Market Concentration Degree
5 Hemophilia Treatment Regional Market Analysis
5.1 Hemophilia Treatment Production by Regions
5.1.1 Global Hemophilia Treatment Production by Regions
5.1.2 Global Hemophilia Treatment Revenue by Regions
5.2 Hemophilia Treatment Consumption by Regions
5.3 North America Hemophilia Treatment Market Analysis
5.3.1 North America Hemophilia Treatment Production
5.3.2 North America Hemophilia Treatment Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Hemophilia Treatment Import and Export
5.4 Europe Hemophilia Treatment Market Analysis
5.4.1 Europe Hemophilia Treatment Production
5.4.2 Europe Hemophilia Treatment Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Hemophilia Treatment Import and Export
5.5 China Hemophilia Treatment Market Analysis
5.5.1 China Hemophilia Treatment Production
5.5.2 China Hemophilia Treatment Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Hemophilia Treatment Import and Export
5.6 Japan Hemophilia Treatment Market Analysis
5.6.1 Japan Hemophilia Treatment Production
5.6.2 Japan Hemophilia Treatment Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Hemophilia Treatment Import and Export
5.7 Southeast Asia Hemophilia Treatment Market Analysis
5.7.1 Southeast Asia Hemophilia Treatment Production
5.7.2 Southeast Asia Hemophilia Treatment Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Hemophilia Treatment Import and Export
5.8 India Hemophilia Treatment Market Analysis
5.8.1 India Hemophilia Treatment Production
5.8.2 India Hemophilia Treatment Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Hemophilia Treatment Import and Export
6 Hemophilia Treatment Segment Market Analysis (by Type)
6.1 Global Hemophilia Treatment Production by Type
6.2 Global Hemophilia Treatment Revenue by Type
6.3 Hemophilia Treatment Price by Type
7 Hemophilia Treatment Segment Market Analysis (by Application)
7.1 Global Hemophilia Treatment Consumption by Application
7.2 Global Hemophilia Treatment Consumption Market Share by Application (2016-2020)
8 Hemophilia Treatment Major Manufacturers Analysis
8.1 CSL Behring
8.1.1 CSL Behring Hemophilia Treatment Production Sites and Area Served
8.1.2 CSL Behring Product Introduction, Application and Specification
8.1.3 CSL Behring Hemophilia Treatment Production, Revenue, Ex-factory Price and Gross Margin (2016-2020)
8.1.4 Main Business and Markets Served
8.2 Baxalta
8.2.1 Baxalta Hemophilia Treatment Production Sites and Area Served
8.2.2 Baxalta Product Introduction, Application and Specification
8.2.3 Baxalta Hemophilia Treatment Production, Revenue, Ex-factory Price and Gross Margin (2016-2020)
8.2.4 Main Business and Markets Served
8.3 Pfizer Inc
8.3.1 Pfizer Inc Hemophilia Treatment Production Sites and Area Served
8.3.2 Pfizer Inc Product Introduction, Application and Specification
8.3.3 Pfizer Inc Hemophilia Treatment Production, Revenue, Ex-factory Price and Gross Margin (2016-2020)
8.3.4 Main Business and Markets Served
8.4 BioMarin
8.4.1 BioMarin Hemophilia Treatment Production Sites and Area Served
8.4.2 BioMarin Product Introduction, Application and Specification
8.4.3 BioMarin Hemophilia Treatment Production, Revenue, Ex-factory Price and Gross Margin (2016-2020)
8.4.4 Main Business and Markets Served
8.5 Bayer Healthcare
8.5.1 Bayer Healthcare Hemophilia Treatment Production Sites and Area Served
8.5.2 Bayer Healthcare Product Introduction, Application and Specification
8.5.3 Bayer Healthcare Hemophilia Treatment Production, Revenue, Ex-factory Price and Gross Margin (2016-2020)
8.5.4 Main Business and Markets Served
8.6 Biogen
8.6.1 Biogen Hemophilia Treatment Production Sites and Area Served
8.6.2 Biogen Product Introduction, Application and Specification
8.6.3 Biogen Hemophilia Treatment Production, Revenue, Ex-factory Price and Gross Margin (2016-2020)
8.6.4 Main Business and Markets Served
8.7 Novo Nordisk
8.7.1 Novo Nordisk Hemophilia Treatment Production Sites and Area Served
8.7.2 Novo Nordisk Product Introduction, Application and Specification
8.7.3 Novo Nordisk Hemophilia Treatment Production, Revenue, Ex-factory Price and Gross Margin (2016-2020)
8.7.4 Main Business and Markets Served
8.8 Roche
8.8.1 Roche Hemophilia Treatment Production Sites and Area Served
8.8.2 Roche Product Introduction, Application and Specification
8.8.3 Roche Hemophilia Treatment Production, Revenue, Ex-factory Price and Gross Margin (2016-2020)
8.8.4 Main Business and Markets Served
8.9 Shire Plc
8.9.1 Shire Plc Hemophilia Treatment Production Sites and Area Served
8.9.2 Shire Plc Product Introduction, Application and Specification
8.9.3 Shire Plc Hemophilia Treatment Production, Revenue, Ex-factory Price and Gross Margin (2016-2020)
8.9.4 Main Business and Markets Served
9 Development Trend of Analysis of Hemophilia Treatment Market
9.1 Global Hemophilia Treatment Market Trend Analysis
9.1.1 Global Hemophilia Treatment Market Size (Volume and Value) Forecast 2021-2027
9.2 Hemophilia Treatment Regional Market Trend
9.2.1 North America Hemophilia Treatment Forecast 2021-2027
9.2.2 Europe Hemophilia Treatment Forecast 2021-2027
9.2.3 China Hemophilia Treatment Forecast 2021-2027
9.2.4 Japan Hemophilia Treatment Forecast 2021-2027
9.2.5 Southeast Asia Hemophilia Treatment Forecast 2021-2027
9.2.6 India Hemophilia Treatment Forecast 2021-2027
9.3 Hemophilia Treatment Market Trend (Product Type)
9.4 Hemophilia Treatment Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Hemophilia Treatment Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
List of Tables and Figures
List of Tables and Figures
Figure Picture of Hemophilia Treatment
Table Global Hemophilia Treatment Production (K Units) Growth Rate Comparison by Types (2016-2027)
Figure Global Hemophilia Treatment Production Market Share by Types in 2020
Figure On-demand Product Picture
Figure prophylaxis Product Picture
Table Global Hemophilia Treatment Consumption (K Units) Comparison by Applications (2016-2027)
Figure Global Hemophilia Treatment Consumption Market Share by Applications in 2020
Figure Replacement therapy
Figure ITI therapy
Figure Gene therapy
Figure Global Hemophilia Treatment Revenue (Million USD) (2016-2027)
Figure Global Hemophilia Treatment Production (K Units) (2016-2027)
Figure North America Hemophilia Treatment Market Size (Million USD) (2016-2027)
Figure Europe Hemophilia Treatment Market Size (Million USD) (2016-2027)
Figure China Hemophilia Treatment Market Size (Million USD) (2016-2027)
Figure Japan Hemophilia Treatment Market Size (Million USD) (2016-2027)
Figure Southeast Asia Hemophilia Treatment Market Size (Million USD) (2016-2027)
Figure India Hemophilia Treatment Market Size (Million USD) (2016-2027)
Table Hemophilia Treatment Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Hemophilia Treatment in 2020
Figure Manufacturing Process Analysis of Hemophilia Treatment
Figure Industry Chain Structure of Hemophilia Treatment
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Hemophilia Treatment Manufacturing Plants Distribution
Table Hemophilia Treatment Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Hemophilia Treatment Capacity (K Units) of Major Manufacturers (2016-2020)
Table Hemophilia Treatment Production (K Units) of Major Manufacturers (2016-2020)
Table Hemophilia Treatment Production Market Share of Major Manufacturers (2016-2020)
Figure Hemophilia Treatment Production Share by Manufacturers in 2020
Table Hemophilia Treatment Revenue (Million US$) of Major Manufacturers (2016-2020)
Table Hemophilia Treatment Revenue Market Share of Major Manufacturers (2016-2020)
Figure Hemophilia Treatment Revenue Share by Manufacturers in 2020
Table Hemophilia Treatment Average Price (USD/Unit) of Major Manufacturers (2016-2020)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Hemophilia Treatment Production by Regions 2016-2020 (K Units)
Table Global Hemophilia Treatment Production Market Share by Regions 2016-2020
Figure Global Hemophilia Treatment Production Market Share by Regions in 2020
Table Global Hemophilia Treatment Revenue by Regions 2016-2020 (Million USD)
Table Global Hemophilia Treatment Revenue Market Share by Regions 2016-2020
Figure Global Hemophilia Treatment Revenue Market Share by Regions in 2020
Table Global Hemophilia Treatment Consumption by Regions 2016-2020 (K Units)
Table Global Hemophilia Treatment Consumption Market Share by Regions 2016-2020
Figure North America Hemophilia Treatment Production Growth Rate 2016-2020 (K Units)
Figure North America Hemophilia Treatment Revenue Growth Rate 2016-2020 (Million USD)
Table North America Hemophilia Treatment Production, Consumption Import and Export (K Units)
Figure Europe Hemophilia Treatment Production Growth Rate 2016-2020 (K Units)
Figure Europe Hemophilia Treatment Revenue Growth Rate 2016-2020 (Million USD)
Table Europe Hemophilia Treatment Production, Consumption Import and Export (K Units)
Figure China Hemophilia Treatment Production Growth Rate 2016-2020 (K Units)
Figure China Hemophilia Treatment Revenue Growth Rate 2016-2020 (Million USD)
Table China Hemophilia Treatment Production, Consumption Import and Export (K Units)
Figure Japan Hemophilia Treatment Production Growth Rate 2016-2020 (K Units)
Figure Japan Hemophilia Treatment Revenue Growth Rate 2016-2020 (Million USD)
Table Japan Hemophilia Treatment Production, Consumption Import and Export (K Units)
Figure Southeast Asia Hemophilia Treatment Production Growth Rate 2016-2020 (K Units)
Figure Southeast Asia Hemophilia Treatment Revenue Growth Rate 2016-2020 (Million USD)
Table Southeast Asia Hemophilia Treatment Production, Consumption Import and Export (K Units)
Figure India Hemophilia Treatment Production Growth Rate 2016-2020 (K Units)
Figure India Hemophilia Treatment Revenue Growth Rate 2016-2020 (Million USD)
Table India Hemophilia Treatment Production, Consumption Import and Export (K Units)
Figure Global Consumption Hemophilia Treatment Market Share by Application (2016-2020)
Figure Global Value (Consumption) Hemophilia Treatment Market Share by Application (2016-2020)
Table CSL Behring Hemophilia Treatment Production Sites and Area Served
Table CSL Behring Hemophilia Treatment Product Introduction, Application and Specification
Table CSL Behring Hemophilia Treatment Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2016-2020)
Table CSL Behring Hemophilia Treatment Production Growth Rate (2016-2020)
Table CSL Behring Hemophilia Treatment Production Market Share (2016-2020)
Figure CSL Behring Hemophilia Treatment Revenue Market Share (2016-2020)
Table CSL Behring Hemophilia Treatment Main Business and Markets Served
Table Baxalta Hemophilia Treatment Production Sites and Area Served
Table Baxalta Hemophilia Treatment Product Introduction, Application and Specification
Table Baxalta Hemophilia Treatment Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2016-2020)
Table Baxalta Hemophilia Treatment Production Growth Rate (2016-2020)
Table Baxalta Hemophilia Treatment Production Market Share (2016-2020)
Figure Baxalta Hemophilia Treatment Revenue Market Share (2016-2020)
Table Baxalta Hemophilia Treatment Main Business and Markets Served
Table Pfizer Inc Hemophilia Treatment Production Sites and Area Served
Table Pfizer Inc Hemophilia Treatment Product Introduction, Application and Specification
Table Pfizer Inc Hemophilia Treatment Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2016-2020)
Table Pfizer Inc Hemophilia Treatment Production Growth Rate (2016-2020)
Table Pfizer Inc Hemophilia Treatment Production Market Share (2016-2020)
Figure Pfizer Inc Hemophilia Treatment Revenue Market Share (2016-2020)
Table Pfizer Inc Hemophilia Treatment Main Business and Markets Served
Table BioMarin Hemophilia Treatment Production Sites and Area Served
Table BioMarin Hemophilia Treatment Product Introduction, Application and Specification
Table BioMarin Hemophilia Treatment Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2016-2020)
Table BioMarin Hemophilia Treatment Production Growth Rate (2016-2020)
Table BioMarin Hemophilia Treatment Production Market Share (2016-2020)
Figure BioMarin Hemophilia Treatment Revenue Market Share (2016-2020)
Table BioMarin Hemophilia Treatment Main Business and Markets Served
Table Bayer Healthcare Hemophilia Treatment Production Sites and Area Served
Table Bayer Healthcare Hemophilia Treatment Product Introduction, Application and Specification
Table Bayer Healthcare Hemophilia Treatment Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2016-2020)
Table Bayer Healthcare Hemophilia Treatment Production Growth Rate (2016-2020)
Table Bayer Healthcare Hemophilia Treatment Production Market Share (2016-2020)
Figure Bayer Healthcare Hemophilia Treatment Revenue Market Share (2016-2020)
Table Bayer Healthcare Hemophilia Treatment Main Business and Markets Served
Table Biogen Hemophilia Treatment Production Sites and Area Served
Table Biogen Hemophilia Treatment Product Introduction, Application and Specification
Table Biogen Hemophilia Treatment Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2016-2020)
Table Biogen Hemophilia Treatment Production Growth Rate (2016-2020)
Table Biogen Hemophilia Treatment Production Market Share (2016-2020)
Figure Biogen Hemophilia Treatment Revenue Market Share (2016-2020)
Table Biogen Hemophilia Treatment Main Business and Markets Served
Table Novo Nordisk Hemophilia Treatment Production Sites and Area Served
Table Novo Nordisk Hemophilia Treatment Product Introduction, Application and Specification
Table Novo Nordisk Hemophilia Treatment Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2016-2020)
Table Novo Nordisk Hemophilia Treatment Production Growth Rate (2016-2020)
Table Novo Nordisk Hemophilia Treatment Production Market Share (2016-2020)
Figure Novo Nordisk Hemophilia Treatment Revenue Market Share (2016-2020)
Table Novo Nordisk Hemophilia Treatment Main Business and Markets Served
Table Roche Hemophilia Treatment Production Sites and Area Served
Table Roche Hemophilia Treatment Product Introduction, Application and Specification
Table Roche Hemophilia Treatment Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2016-2020)
Table Roche Hemophilia Treatment Production Growth Rate (2016-2020)
Table Roche Hemophilia Treatment Production Market Share (2016-2020)
Figure Roche Hemophilia Treatment Revenue Market Share (2016-2020)
Table Roche Hemophilia Treatment Main Business and Markets Served
Table Shire Plc Hemophilia Treatment Production Sites and Area Served
Table Shire Plc Hemophilia Treatment Product Introduction, Application and Specification
Table Shire Plc Hemophilia Treatment Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2016-2020)
Table Shire Plc Hemophilia Treatment Production Growth Rate (2016-2020)
Table Shire Plc Hemophilia Treatment Production Market Share (2016-2020)
Figure Shire Plc Hemophilia Treatment Revenue Market Share (2016-2020)
Table Shire Plc Hemophilia Treatment Main Business and Markets Served
Figure Global Hemophilia Treatment Production (K Units) Growth Rate Forecast 2021-2027
Figure Global Hemophilia Treatment Revenue (Million USD) Growth Rate Forecast 2021-2027
Figure Global Hemophilia Treatment Sales Price (USD/Unit) Forecast 2021-2027
Figure North America Hemophilia Treatment Production Growth Rate Forecast 2021-2027 (K Units)
Figure North America Hemophilia Treatment Revenue Growth Rate Forecast 2021-2027 (Million USD)
Figure Europe Hemophilia Treatment Production Growth Rate Forecast 2021-2027 (K Units)
Figure Europe Hemophilia Treatment Revenue Growth Rate Forecast 2021-2027 (Million USD)
Figure China Hemophilia Treatment Production Growth Rate Forecast 2021-2027 (K Units)
Figure China Hemophilia Treatment Revenue Growth Rate Forecast 2021-2027 (Million USD)
Figure Japan Hemophilia Treatment Production Growth Rate Forecast 2021-2027 (K Units)
Figure Japan Hemophilia Treatment Revenue Growth Rate Forecast 2021-2027 (Million USD)
Figure Southeast Asia Hemophilia Treatment Production Growth Rate Forecast 2021-2027 (K Units)
Figure Southeast Asia Hemophilia Treatment Revenue Growth Rate Forecast 2021-2027 (Million USD)
Figure India Hemophilia Treatment Production Growth Rate Forecast 2021-2027 (K Units)
Figure India Hemophilia Treatment Revenue Growth Rate Forecast 2021-2027 (Million USD)
Table Global Production (K Units) of Hemophilia Treatment by Type (2021-2027)
Table Global Consumption (K Units) of Hemophilia Treatment by Application (2021-2027)
Table Hemophilia Treatment Distributors List
Table Hemophilia Treatment Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources